Atraumatic Restorative Treatment (ART)

United Kingdom National Institute for Health and Care Excellence (NICE) Publishes Interventional Procedure Guidance (IPG) for ReActiv8® Restorative Neurostimulation™

Retrieved on: 
Friday, September 23, 2022
Nursing, Medical Devices, Surgery, Hospitals, Fitness & Nutrition, Biotechnology, Alternative Medicine, Managed Care, General Health, Health, European Economic Area, Â, Time, National Health Service (England), NHS, Safety, Department, Risk, Clinical governance, Multifidus muscle, Leeds Teaching Hospitals NHS Trust, Forward-looking statement, Department of Health and Social Care, Patient, Physician, CEO, Technology, Pain, Pathology, Uncertainty, National Health Service, Consultant, National Institute for Health and Care Excellence, Research, NICE, Atraumatic Restorative Treatment (ART), National Institute, Pharmaceutical industry, Dentistry

ReActiv8 is currently the only technology offering restorative neurostimulation to the NHS for refractory mechanical chronic low back pain (CLBP).

Key Points: 
  • ReActiv8 is currently the only technology offering restorative neurostimulation to the NHS for refractory mechanical chronic low back pain (CLBP).
  • This new guidance will enable patients to have greater access to the therapy when previous treatment options have not proven successful.
  • This new guidance will allow more patients to gain access to ReActiv8 within the U.K. and further afield.
  • Mainstay Medical is a medical device company focused on commercializing its innovative implantable Restorative Neurostimulation system, ReActiv8, for people with disabling mechanical CLBP.

clinical data show significantly lower iud procedural pain and bleeding rates with aspivix's novel SUCTION-BASED CERVICAL Device

Retrieved on: 
Wednesday, May 25, 2022
Department, Adolescence, Vacuum, Pain, Company, Michel Bernholc, Traction, Comparison, SA, Birth control, Fear, Norwest Venture Partners, Trauma, HUG, ZKB, European Society of Gynaecological Oncology, New Oakland Child-Adolescent and Family Center, Method, Birth, Advancing Women Artists Foundation, Designated terrorist organisations in Australia, Intrauterine device, Bleeding, IUD, Congress, Safety, Reproduction, Lausanne University Hospital, Geneva University Hospitals, CHUV, Atraumatic Restorative Treatment (ART), Framework Programmes for Research and Technological Development, Reproductive health, PMID, Woman

Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.

Key Points: 
  • Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.
  • During IUD insertion, twice as many nulliparouswomenin the Carevix group were free of pain compared to those in the tenaculum group, and they reported an 88% lower rate of severe pain.
  • Carevixis an innovative, soft-suction cervical device designed as a modern and gentler alternative to a cervical tenaculum when stabilization of the cervix is needed.
  • A semi-circular, anatomical pad is applied onto the delicate tissue during gynecological procedures, reducing trauma associated with pain and bleeding.

CLINICAL DATA SHOW SIGNIFICANTLY LOWER IUD PROCEDURAL PAIN AND BLEEDING RATES WITH ASPIVIX'S NOVEL SUCTION-BASED CERVICAL DEVICE

Retrieved on: 
Wednesday, May 25, 2022
Department, Adolescence, Vacuum, Pain, Company, Michel Bernholc, Traction, Comparison, SA, Birth control, Fear, Norwest Venture Partners, Trauma, HUG, ZKB, European Society of Gynaecological Oncology, New Oakland Child-Adolescent and Family Center, Method, Birth, Designated terrorist organisations in Australia, Advancing Women Artists Foundation, Intrauterine device, Bleeding, IUD, Congress, Safety, Reproduction, Lausanne University Hospital, Geneva University Hospitals, CHUV, Atraumatic Restorative Treatment (ART), Framework Programmes for Research and Technological Development, Reproductive health, PMID, Woman

Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.

Key Points: 
  • Pain scores were 52% lower with the Carevix device during cervix grasping, 53% lower during cervix stabilization (traction), 30% lower during IUD insertion, and 33% lower during cervix release, compared to tenaculum use.
  • During IUD insertion, twice as many nulliparouswomenin the Carevix group were free of pain compared to those in the tenaculum group, and they reported an 88% lower rate of severe pain.
  • Carevixis an innovative, soft-suction cervical device designed as a modern and gentler alternative to a cervical tenaculum when stabilization of the cervix is needed.
  • A semi-circular, anatomical pad is applied onto the delicate tissue during gynecological procedures, reducing trauma associated with pain and bleeding.